Alkermes Plc
NASDAQ:ALKS
Alkermes Plc
Depreciation & Amortization
Alkermes Plc
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Alkermes Plc
NASDAQ:ALKS
|
Depreciation & Amortization
$64.3m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-4%
|
|
Amarin Corporation PLC
NASDAQ:AMRN
|
Depreciation & Amortization
$3m
|
CAGR 3-Years
13%
|
CAGR 5-Years
35%
|
CAGR 10-Years
13%
|
|
Prothena Corporation PLC
NASDAQ:PRTA
|
Depreciation & Amortization
$943k
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
2%
|
|
M
|
Mural Oncology PLC
NASDAQ:MURA
|
Depreciation & Amortization
$2.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Alkermes Plc's Depreciation & Amortization?
Depreciation & Amortization
64.3m
USD
Based on the financial report for Mar 31, 2024, Alkermes Plc's Depreciation & Amortization amounts to 64.3m USD.
What is Alkermes Plc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
-4%
Over the last year, the Depreciation & Amortization growth was -17%. The average annual Depreciation & Amortization growth rates for Alkermes Plc have been -7% over the past three years , -8% over the past five years , and -4% over the past ten years .